ArticleDrug delivery2018

Bone-targeted methotrexate-alendronate conjugate inhibits osteoclastogenesis in vitro and prevents bone loss and inflammation of collagen-induced arthritis in vivo.

Zi'ang Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.